În afara temei aiqbench
Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.
Chipscreen Biosciences: NW001 Receives Clinical Trial Approval
36Kr learned that Chipscreen Biosciences announced it recently received a Drug Clinical Trial Approval Notice issued by the National Medical Products Administration. The company's clinical trial application for injectable NW001, developed in cooperation with Chengdu Chipscreen Xinyu Biotechnology Co., Ltd., for the treatment of advanced malignant tumors, has been approved.
Citește articolul complet pe 36KrSubiecte conexe
People might start believing in radical life extension soon
LessWrong · 20 iul. 2026
XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · 19 aug. 2026
Bill Gates Will NOT And CANNOT Inject Us With A Microchip In A Vaccine - Fails Basic Fact Check
science20.com · 20 aug. 2026
EQS - News: Chainwire: INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer Drug Research and Explore New Applications for XPro
finanznachrichten.de · 16 oct. 2026